News - Strattera


Current filters:


Popular Filters

Eli Lilly exceeds expectations with third quarter results

Eli Lilly exceeds expectations with third quarter results


US pharma major Eli Lilly has announced financial results for the third quarter of 2013. Despite the…

AlimtaAmyvidAxironCialisCymbaltaEffientEli LillyEvistaFinancialForteoHumalogNorth AmericaPharmaceuticalStratteraTrajentaZyprexa

Eli Lilly records higher than expected earnings in 2nd-qtr results


US drug major Eli Lilly's (NYSE: LLY) recorded higher than expected earnings as growth in key products…

AlimtaCialisCymbaltaEffientEli LillyEvistaFinancialForteoHumalogNorth AmericaPharmaceuticalStratteraZyprexa

Shire's Elvanse shows significantly faster response in ADHD symptoms than Strattera


Ireland-headquartered Shire (LSE: SHP, NASDAQ: SHPG) presented positive scientific data comparing the…

Eli LillyElvanseNeurologicalPharmaceuticalResearchShireStrattera

Back to top